Cointime

InMed Prognostics

company

About

InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuro radiologists, neuro physicians and psychiatrists.

  • 11 - 50

Highlights

Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Seed
Industries
Artificial Intelligence,Health Care,Machine Learning,Neuroscience,Psychology
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuroradiologists, neuro physicians, and psychiatrists. Its flagship product Neuroshield integrates MRI images, clinical reports, and psychological assessments to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
InMed Prognostics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Dec 16, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 16, 2020 Seed — 1 India EdisonTM Accelerator — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
InMed Prognostics has made 1 investments. Their most recent investment was on Jan 28, 2019, when CreditVidya raised $3M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 28, 2019 CreditVidya
Series B $3M Credit —

Investors

Number of Lead Investors
Number of Investors
1
1
InMed Prognostics is funded by 1 investors. India EdisonTM Accelerator are the most recent investors.
Investor Name Lead Investor Funding Round
India EdisonTM Accelerator Yes Seed
Cointime
เนื้อหา
บริษัท